These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17439313)

  • 21. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals.
    Klare I; Konstabel C; Mueller-Bertling S; Werner G; Strommenger B; Kettlitz C; Borgmann S; Schulte B; Jonas D; Serr A; Fahr AM; Eigner U; Witte W
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):815-25. PubMed ID: 16374593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First report of a linezolid-resistant vancomycin-resistant Enterococcus faecium strain in Greece.
    Bersos Z; Maniati M; Kontos F; Petinaki E; Maniatis AN
    J Antimicrob Chemother; 2004 Apr; 53(4):685-6. PubMed ID: 14985272
    [No Abstract]   [Full Text] [Related]  

  • 23. Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis.
    Graham PL; Ampofo K; Saiman L
    Pediatr Infect Dis J; 2002 Aug; 21(8):798-800. PubMed ID: 12233719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
    Bae HG; Sung H; Kim MN; Lee EJ; Koo Lee S
    Scand J Infect Dis; 2006; 38(5):383-6. PubMed ID: 16709544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
    Herrero IA; Issa NC; Patel R
    N Engl J Med; 2002 Mar; 346(11):867-9. PubMed ID: 11893808
    [No Abstract]   [Full Text] [Related]  

  • 26. Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
    Dobbs TE; Patel M; Waites KB; Moser SA; Stamm AM; Hoesley CJ
    J Clin Microbiol; 2006 Sep; 44(9):3368-70. PubMed ID: 16954275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S; Sinirtaş M; Ozakin C
    Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital.
    de Almeida LM; de Araújo MR; Iwasaki MF; Sacramento AG; Rocha D; da Silva LP; Pavez M; de Brito AC; Ito LC; Gales AC; Lincopan N; Sampaio JL; Mamizuka EM
    Antimicrob Agents Chemother; 2014 May; 58(5):2993-4. PubMed ID: 24614366
    [No Abstract]   [Full Text] [Related]  

  • 30. Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium.
    Schulte B; Heininger A; Autenrieth IB; Wolz C
    Epidemiol Infect; 2008 Aug; 136(8):1131-3. PubMed ID: 17892630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid treatment of shunt-related cerebrospinal fluid infections in children.
    Yilmaz A; Dalgic N; Müslüman M; Sancar M; Colak I; Aydin Y
    J Neurosurg Pediatr; 2010 May; 5(5):443-8. PubMed ID: 20433254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals.
    Reis AO; Cordeiro JC; Machado AM; Sader HS
    Braz J Infect Dis; 2001 Oct; 5(5):243-51. PubMed ID: 11779450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed discovery of linezolid-resistant, vancomycin-resistant Enterococcus faecium: lessons learned.
    Schwartz MD; Shive DK; Shaikh ZH
    Clin Infect Dis; 2004 Jan; 38(1):155-6. PubMed ID: 14679466
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.
    Pai MP; Rodvold KA; Schreckenberger PC; Gonzales RD; Petrolatti JM; Quinn JP
    Clin Infect Dis; 2002 Nov; 35(10):1269-72. PubMed ID: 12410489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
    Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
    Zeana C; Kubin CJ; Della-Latta P; Hammer SM
    Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
    Le J; Bookstaver PB; Rudisill CN; Hashem MG; Iqbal R; James CL; Sakoulas G
    Ann Pharmacother; 2010 Dec; 44(12):2001-6. PubMed ID: 21119097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M; Wixson RL; Pertel PE
    Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis.
    Patel R; Rouse MS; Piper KE; Steckelberg JM
    Antimicrob Agents Chemother; 2001 Feb; 45(2):621-3. PubMed ID: 11158767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.